Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Mumps Vaccine (MumpsVax) Market From 2025 To 2029?
The market for the mumps vaccine (mumpsvax) has seen robust growth in recent years. The market size is predicted to rise from $2,057.93 million in 2024 to $2,210.59 million in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. The driving factors behind this surge during the historic period include augmented pediatric vaccination rates, enhanced global health initiatives, growing public confidence in vaccines, more awareness about travel, and a rise in vaccination campaigns.
What Is the Projected Market Size of the Mumps Vaccine (MumpsVax) Market?
The market for mumps vaccine (mumpsvax) is projected to witness significant expansion in the imminent years, growing to a value of $2,902.21 million in 2029 with a compound annual growth rate (CAGR) of 7.0%. The expected growth throughout the forecasted timeline can be ascribed to escalating numbers of diseases that can be prevented with vaccines, amplified awareness of adult immunizations, burgeoning health cognizance, expanded implementation of immunization programs, and an uptick in global health initiatives. Some anticipated trends for the forecast period encompass individualized immunization tactics, the amalgamation of digital health, improved surveillance systems, exploratory research on adult immunization, and the merger of artificial intelligence.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
Who are the Major Competitors in the Mumps Vaccine (MumpsVax) Market Outlook?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
What Is Fueling Growth in the Mumps Vaccine (MumpsVax) Market?
The escalating occurrence of infectious diseases is set to spur the expansion of the mumps vaccine (mumpsvax) market. These diseases, resulting from pathogenic microorganisms, can be transferred from one person to another or through polluted surroundings. The rising prevalence of these infections is attributed to factors like urbanization, climate change, globalization and changes in demographic and human behavior patterns, which facilitate the spread and emergence of pathogens. Mumpsvax, specifically designed to prevent mumps infection, is often part of the MMR (measles, mumps, rubella) vaccination. Notably, in August 2024, a UK Health Security Agency report noted the highest number of measles cases, 160 and 122, in the West Midlands region and London, respectively, in 2023. It was also observed that children aged 10 and below accounted for 63% of these cases, with a surge in measles cases at the year’s end. Hence, the rising prevalence of infectious diseases is boosting the mumps vaccine (mumpsvax) market. Increasing healthcare spending is foreseen to accelerate the growth of the mumps vaccine (mumpsvax) market. This expenditure includes costs for personal health care, preventive services, and public health activities aimed at enhancing health outcomes. Factors such as aging population, chronic illnesses, advanced medical technology, high drug prices, inefficient payment models, and elevated service demand contribute to this rise in healthcare spending. Increased expenditure can assist mumps vaccine (mumpsvax) through the provision of funds for vaccination efforts, thereby promoting vaccine accessibility and improved public health via higher mumps immunization rates. For instance, according to a report by the Office For National Statistics in May 2024, total healthcare spending increased by 5.6% from 2022 to 2023, along with a 2.8% rise in total long-term health and social care spending in 2022. Therefore, increased healthcare expenditure trends are propelling the mumps vaccine (mumpsvax) market forward.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19909&type=smp
Which Mumps Vaccine (MumpsVax) Market Segments Are Growing the Fastest?
The mumps vaccine (mumpsvax)market covered in this report is segmented –
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
Which Countries Are Leading the Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909
This Report Delivers Insight On:
1. How big is the mumps vaccine (mumpsvax) market, and how is it changing globally?
2. Who are the major companies in the mumps vaccine (mumpsvax) market, and how are they performing?
3. What are the key opportunities and risks in the mumps vaccine (mumpsvax) market right now?
4. Which products or customer segments are growing the most in the mumps vaccine (mumpsvax) market?
5. What factors are helping or slowing down the growth of the mumps vaccine (mumpsvax) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model